APA (7th ed.) Citation

SF, W., JM, U., 3rd, W. J., LI, W., ME, L., KC, H., . . . CM, M. (2020). A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. Journal of patient-reported outcomes, 4(1), 54. https://doi.org/10.1186/s41687-020-00220-x

Chicago Style (17th ed.) Citation

SF, Wong, et al. "A Prospective Study to Validate the Functional Assessment of Cancer Therapy (FACT) for Epidermal Growth Factor Receptor Inhibitor (EGFRI)-induced Dermatologic Toxicities FACT-EGFRI 18 Questionnaire: SWOG S1013." Journal of Patient-reported Outcomes 4, no. 1 (2020): 54. https://doi.org/10.1186/s41687-020-00220-x.

MLA (9th ed.) Citation

SF, Wong, et al. "A Prospective Study to Validate the Functional Assessment of Cancer Therapy (FACT) for Epidermal Growth Factor Receptor Inhibitor (EGFRI)-induced Dermatologic Toxicities FACT-EGFRI 18 Questionnaire: SWOG S1013." Journal of Patient-reported Outcomes, vol. 4, no. 1, 2020, p. 54, https://doi.org/10.1186/s41687-020-00220-x.